US Infectious Disease Diagnostics Market (2025-2030)
The US Infectious Disease Diagnostics Market was valued at $5424 Million in 2025 and projected to reach to $8282.9 Million by 2030, representing a compound annual growth rate of 8.8%. The US Infectious Disease Diagnostics Market is positioned for sustained growth through 2030, driven by technological advancement, regulatory support, and heightened awareness of infectious disease threats.
US Infectious Disease Diagnostics Market Trends and Insights
- The US market benefits from advanced healthcare infrastructure, high adoption of molecular and rapid diagnostic technologies, and substantial investment in infectious disease surveillance.
- Driving this expansion, the US faces increasing prevalence of infectious diseases, growing demand for point-of-care testing, and regulatory support for innovative diagnostic solutions.
- The US diagnostic landscape is characterized by strong competition among established players and emerging innovators, with emphasis on accuracy, speed, and accessibility of testing platforms..
Key Market Statistics
- CAGR (2025-2030) 8.8% CAGR
- Market Size, 2025 ~USD 5424 Million
- Forecast, 2030 ~USD 8282.9 Million
- Country US
US Infectious Disease Diagnostics Market Overview
Market Valuation :
The US Infectious Disease Diagnostics Market is valued at $5,424.0 million in 2025, with projected growth to $8,282.9 million by 2030, driven by advanced healthcare infrastructure and high diagnostic adoption rates.
Robust Growth Trajectory :
The US market demonstrates an 8.8% CAGR from 2025-2030, outpacing many developed markets due to strong healthcare spending, FDA approvals for innovative diagnostic platforms, and increased demand for rapid testing solutions.
Technology Leadership :
US healthcare providers lead in molecular and rapid diagnostic technology adoption, with significant investments in PCR, next-generation sequencing, and point-of-care testing platforms across hospitals, clinics, and laboratories.
Surveillance Infrastructure :
Substantial federal and state investment in infectious disease surveillance systems, including CDC initiatives and pandemic preparedness programs, strengthens the US market's foundation for diagnostic innovation and deployment.
US Infectious Disease Diagnostics Market Dynamics
- Healthcare providers increasingly prioritize rapid, accurate diagnostics to improve patient outcomes and reduce healthcare costs.
- The integration of AI-powered diagnostic tools and automation in laboratory settings will accelerate market expansion.
- Additionally, post-pandemic investments in diagnostic infrastructure and surveillance capabilities continue to strengthen market fundamentals.
- Competitive dynamics among major diagnostic manufacturers will drive innovation and pricing optimization across molecular, immunological, and point-of-care segments..
Related Ecosystem
In Vitro Diagnostics
Medical Devices
Key Takeaways
- The US Infectious Disease Diagnostics Market will grow from $5,424.0M (2025) to $8,282.9M (2030) at an 8.8% CAGR.
- The US market is driven by advanced healthcare infrastructure and high adoption of molecular and rapid diagnostic technologies.
- Point-of-care testing and regulatory support for innovative solutions are accelerating growth in the US market.
- The US competitive landscape features both established diagnostic leaders and emerging innovators focused on speed and accessibility.
Infectious Disease Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOSQUITO-BORNE DISEASES (Disease Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.7% from 2025 to 2030 |
| Largest Segment | LABORATORY TESTING (Type Of Testing) |
| Market Size Base Year (Billions) | ~USD 26.56 (2025) |
| Revenue Forecast (Billions) | ~USD 42.2 (2030) |
| Segments Covered | Product & Service, Type Of Testing, Sample Type, Disease Type, Type, Technology |
US Infectious Disease Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents, Kits, And Consumables
- Software & Services
By Type Of Testing
- Laboratory Testing
- Poc Testing
By Sample Type
- Blood, Serum, And Plasma
- Other Sample Types
- Urine
By Disease Type
- Chlamydia Trachomatis
- Hepatitis
- Hiv
- Hospital-Acquired Infections
- Hpv
- Influenza
- Mosquito-Borne Diseases
- Neisseria Gonorrhea
- Other Infectious Diseases
- Syphilis
- Tuberculosis
By Type
- Hepatitis B
- Hepatitis C
- Other Hepatitis Diseases
By Technology
- Clinical Microbiology
- Dna Microarray
- Dna Sequencing & Next-Generation Sequencing
- Immunodiagnostics
- Isothermal Nucleic Acid Amplification Technology
- Other Technologies
- Polymerase Chain Reaction
Target Audience
- Diagnostic Device Manufacturers : Manufacturers need US-specific market data to guide product development, regulatory submissions, and commercial strategies for molecular, immunological, and point-of-care diagnostic platforms.
- Healthcare System Administrators : Hospital networks and laboratory directors require market insights to optimize diagnostic procurement, evaluate emerging technologies, and align testing capabilities with evolving clinical and surveillance needs.
- Investment and Private Equity Firms : Investors need comprehensive US market analysis to identify acquisition targets, assess growth potential, and make informed decisions on diagnostic company valuations and portfolio expansion opportunities.
- Regulatory and Policy Advisors : Government agencies, policy makers, and regulatory consultants use market data to inform FDA guidance, reimbursement policies, and public health surveillance strategies for infectious disease diagnostics.
- Clinical Laboratory Networks : Independent and hospital-based laboratories need US market trends to evaluate diagnostic test portfolios, assess competitive positioning, and plan capital investments in testing infrastructure and automation.
Key Companies in the US Infectious Disease Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Strategic Market Sizing : Obtain precise US market valuation ($5.4B in 2025) and 2030 forecasts to benchmark competitive positioning, allocate R&D budgets, and identify growth opportunities within the American diagnostic landscape.
- Growth Trajectory Insights : Understand the 8.8% CAGR drivers specific to the US market, including regulatory trends, reimbursement policies, and healthcare infrastructure investments to inform expansion strategies and product development priorities.
- Technology Adoption Patterns : Analyze US adoption rates for molecular, rapid, and point-of-care diagnostics to identify market gaps, competitive advantages, and opportunities for differentiation in high-growth diagnostic segments.
- Regulatory and Compliance Framework : Navigate FDA approval pathways, reimbursement landscapes, and compliance requirements specific to the US market to accelerate product launches and optimize market entry strategies for diagnostic solutions.
- Competitive Intelligence : Benchmark against US market leaders, assess emerging competitors, and identify partnership opportunities within the American healthcare ecosystem to strengthen market positioning and revenue growth.
Frequently asked questions
What is the current size of the US Infectious Disease Diagnostics Market?
The US Infectious Disease Diagnostics Market is valued at $5,424.0 million in 2025.
What is the projected size of the US market by 2030?
The US Infectious Disease Diagnostics Market is projected to reach $8,282.9 million by 2030.
What is the growth rate of the US Infectious Disease Diagnostics Market?
The US market is expected to grow at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2030.
What factors are driving growth in the US Infectious Disease Diagnostics Market?
Key drivers in the US include increasing infectious disease prevalence, growing demand for point-of-care testing, advanced healthcare infrastructure, and regulatory support for innovative diagnostic solutions.
What technologies are prominent in the US Infectious Disease Diagnostics Market?
The US market is characterized by high adoption of molecular diagnostics, rapid testing platforms, and point-of-care testing technologies that emphasize accuracy and speed.
RESEARCH METHODOLOGY
The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. The objectives include tracking company developments such as acquisitions, product/service launches & approvals, expansions, agreements, and partnerships of the leading players. These parameters were evaluated on various parameters within the broad business & product strategy categories. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify & collect information for this study.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative & quantitative information for this report. Primary sources included experts from the core & related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain & verify critical qualitative & quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott (US) | Sales Manager |
| Becton, Dickinson and Company (US) | Product Manager |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the infectious disease diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the infectious disease diagnostics market have been determined through primary & secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Infectious disease diagnostics can be defined as various techniques and products (including kits, assays, tests, reagents, and analyzers) used by healthcare professionals to detect and diagnose disease-causing pathogens in human samples such as serum, blood, urine, throat swabs, and stool, among others.
Stakeholders
- Manufacturers & distributors of infectious disease diagnostics
- IVD companies
- Hospitals & clinics
- Academic research institutes
- Diagnostic laboratories
- Blood banks
- Home health agencies
- Market research & consulting firms
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global infectious disease diagnostics market by product & service, type of testing, sample type, disease type, technology, clinical application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall infectious disease diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the infectious disease diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Get the Full Infectious Disease Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Infectious Disease Diagnostics Market.
- Canada Infectious Disease Diagnostics Market
- Germany Infectious Disease Diagnostics Market
- UK Infectious Disease Diagnostics Market
- France Infectious Disease Diagnostics Market
- Italy Infectious Disease Diagnostics Market
- Spain Infectious Disease Diagnostics Market
- China Infectious Disease Diagnostics Market
- Japan Infectious Disease Diagnostics Market
- India Infectious Disease Diagnostics Market
- Brazil Infectious Disease Diagnostics Market
- Mexico Infectious Disease Diagnostics Market
- United Arab Emirates Infectious Disease Diagnostics Market
- Rest Of Europe Infectious Disease Diagnostics Market
- Rest Of Asia Pacific Infectious Disease Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report